Member Info for oldsharedog

Smiler - take your profit from you know where & get it in here where it belongs ;)

If in doubt see my previous post in TRLS !!

IMHO - DYOR

Magpie - take today’s profit and put it back where it belongs :)

OSD - DYOR

Jkemp - have you not worked out that OTM is a paid troll :)

Start of a gradual rise ??

all4 - i have had a message from my co worker andreas to let me know he has received the flares for good friday - i asked him to order an extra one for when qbt gets rocketing:)

got the feeling that it will not be long before we get more positive news here & the sp shoots upwards - just a gut feeling & 2 ****tails.

osd - hot & not bothered 😇

We need MSUK to post a positive chart - even if it’s made up I don’t care - he was right - I was wrong.

Any information in this post is not to be used by 3rd parties or gloaters 🤣🤣🤣

A few posters have eluded to being led down the garden path here, which in the light of other shares and BODs is understandable. A good example is IMM - where the information given has upset a huge swath of investors - and I as a result sold my remaining shares yesterday, but am confident enough to have placed them directly into NFX - as the information and messages have remained consistent and plausible.

In a recent RNS I believe that they eluded to a deal will be announced shortly after the FDA award - I am not going to second guess that timeframe - but the confidence shown to date only points to a swift announcement ( maybe within the next month ). That's my best guess and only a guess !!

As I have previously stated my BIG disappointment is that the SP is not where I envisaged - maybe if it were around .5 or slightly higher I would feel very smug - as it is, it is now going to have to be at the higher level of deals to realise my own target here - 2p within 12 months.

OSD - looking out for partners ( FFX also watching out !! )

KK - I totally agree with you on one thing - never invest what you cannot afford. It will guarantee that you will gamble everything away.

Unfortunately a lot of gamblers who can’t afford to lose will not take your advice.

OSD - other shares are available 😇

Nico - Big news would evaluate to finding one of the BODs - unfortunately that doesn't seem likely at the moment - I think we are losing against the world champion hide and seek team :)

All4 - the barometer has just suddenly changed, and the indicator points at untold riches on the wind.

All cleats will be cast in gold and ropes wound with silk !!

The new rig will bring us all the rewards we’ve been waiting for 😇

I’m going to invite Phimx to take photos of the launch 🤣🤣🤣

FFX - turn the screen off - it wont change a thing watching every move.

Maybe go paint drying watching - it will have faster results I guess :)

ATB - OSD

Don't fret we're still OK !!

Roger - quite right a lot of praise - until of course I stumbled on something and tried to warn everyone to sell - at which point everyone turned against me thinking I had lost the plot - WHO'S LAUGHING NOW - I sold 50% @ 15.6p the remaining 90% @ 8.1p & today the remainder @ 6.3p - all of which were purchased at 1.4p

I now know that when someone gets a following that is bigger and more powerful than the paid agitators on a stock, they are removed and not able to post again on that stock - strange that isn't it - maybe they knew that I had gathered the info put 2+2 together - with a little experience and contacts :) and curtailed my warnings to ensure more ppl were suckered in maybe - AIMHO

Please feel free to post this over at IMM ( or any one else for that matter ) and send my regards to Halfbutt one of the few genuine investors with morals.

Roger - you will probably report and have this deleted as you to are probably in the fold - so to speak.

Finally Roger you posted " OSD is a poster NOT to be trusted" - I think I have made the case clear and remain committed to the best outcome on all my investments.

P.S. I entered here at .630 so have quite a way to go to get back counting any profits yet - but I do believe they will arrive.

Now someone post this over on IMM if you would be so kind.

OSD - Considering a sermon for Sunday :)

Redhammy - congratulations & thank you for your contribution to public safety & wellbeing. 👏👏👏👏👏

Spacker - you're probably right with your guru like status on these boards & your never ending positive posts, on shares that you will never have the funds to buy.

Thank you for your free tuition on how to be a pilchard !

OSD - I wish it was my buy :)

10k buyer :)

Someone has still got the cahooners :)

Cont. Game changer and decision is on the near horizon.

All these elements / scenarios are worth discussing - one of them is going to transpire soon.

DYOR

OSD - let the tests multiply !!!

INSURER / PRIVATE CLINICS - SCENARIO

🧬 Private Hospital Groups Most Likely to Adopt EpiSwitch Next

This is a ranked, scenario‑based adoption model based on:

• existing molecular diagnostics usage

• oncology/urology service lines

• insurer relationships

• commercial incentives

• footprint and decentralised testing capability

🥇 Tier 1 — High‑Probability Early Adopters

1. HCA Healthcare UK

Why they’re top of the list:

• Largest private oncology footprint in the UK

• Heavy investment in precision medicine and genomic profiling

• Already use advanced liquid biopsy and molecular diagnostics

• Serve high‑acuity patients where CiRT (immunotherapy response prediction) is directly relevant

Strategic fit:

• CiRT aligns with their immunotherapy pathways

• PSE fits their prostate cancer screening programmes

• HCA patients are the demographic most likely to pay for advanced tests

Likelihood: Very high

2. Nuffield Health

Why they’re strong candidates:

• Large national footprint with strong urology services

• Already offer PSA, MRI, and advanced screening packages

• Competitive pressure from Bupa‑aligned clinics

Strategic fit:

• PSE is a natural upgrade to their men’s health screening packages

• CiRT could be offered through their oncology partners

Likelihood: High

3. Circle Health Group (formerly BMI Healthcare)

Why they’re in the frame:

• Big oncology and urology presence

• Aggressive in adopting new diagnostics to differentiate from Spire

• Large insured patient base (Bupa, AXA, Aviva)

Strategic fit:

• PSE fits their men’s health and screening bundles

• CiRT fits their oncology centres

Likelihood: High

🥈 Tier 2 — Medium‑Probability Adopters

4. Spire Healthcare

Why they’re not first but still plausible:

• Strong urology footprint

• But slower to adopt novel diagnostics unless insurer‑driven

• No public evidence they use EpiSwitch yet

• More conservative commercial model

Strategic fit:

• PSE is a good match for their prostate pathways

• CiRT less likely unless insurer‑mandated

Likelihood: Medium

There are far more tier 2 examples - but I think that's enough for now !!

The more interesting thing for me is as follows :

🔍 What will actually trigger adoption?

Here are the real catalysts:

1. Insurer reimbursement expansion

If AXA, Aviva, or Vitality follow Bupa, adoption will accelerate across all major hospital groups.

2. Consultant‑led pull

Urologists and oncologists adopting PSE or CiRT in private practice will drag hospitals with them.

3. Competitive pressure

If HCA or Nuffield adopt PSE first, Circle and Spire will follow to avoid losing screening patients.

4. Published real‑world data

More peer‑reviewed evidence → faster institutional uptake.

Consider that there may be conversations being held between Government and Insurer bodies to speed the uptake / delivery of PSA testing, funded or re imbursed. Then that would be a game changer - and decision time is on the near h

Agakhan - technically as stated it would normally be June - however if the trend that they outlined in their previous RNS re update on EpiSwitch, continues, and there is market discussions to support its growth, then there would be an update sooner.

Considering all the forthcoming interest in the NHS direction on screening etc - I wouldn't be surprised to see another 'spike' in the SP, which in turn would prompt further news being released - whether that would be useful or not remains to be seen.

My best guess is that there will be an RNS detailing uptake shortly - as this would also send a message across the broader market, and keep OBD at the forefront of peoples decision making.

Definitely a hold at present & an opportunity for some to increase their stake here, whilst awaiting any further news.

DYOR - AIMHO

OSD - GLA

TheJam - maybe look at the previous info re figures and not take just my word for it :)

Sales are increasing month on month

BUPA - recently taken on board EpiSwitch tech.

USA - Private Insurance Comps - taking on OBDs EpiSwitch

But Jam - Don't take my word for it - read the medical journals.

OSD - Editor in chief of EpiSwitch uptakes :)

Pension - sorry to hear of your experience - especially the argument side - hopefully a full recognition of the tech here will re rate this. I was fortunate enough to enter at a low level, but still in negative territory here - but when this moves it will move so quickly, just one decent contract will start a domino effect IMHO. Everyone keeps saying NHS but the USA markets are very buoyant and building month on month. revenue count is all important and as long as that keeps heading in the right direction, this should at some stage start reacting.

We are due figures again shortly, that will be interesting.

GLA - OSD